CEO
A3P Biomedical
The startup offers a blood test service that combines protein markers, genetic markers, and clinical data analyzed through an algorithm to detect aggressive prostate cancer at an early stage. This service aims to reduce prostate cancer mortality by enabling timely intervention and improving men's health outcomes.
- Digital Health
- Healthcare Technology
Updated 7 months ago
Funding
Raised to date
$54MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup offers a blood test service that combines protein markers, genetic markers, and clinical data analyzed through an algorithm to detect aggressive prostate cancer at an early stage. This service aims to reduce prostate cancer mortality by enabling timely intervention and improving men's health outcomes.